Beauparlant SL, Read PW, Di Cristofano A. In vivo adenovirus-mediated gene transduction into mouse endometrial glands: a novel tool to model endometrial cancer in the mouse.
Gynecol Oncol 2004;
94:713-8. [PMID:
15350363 DOI:
10.1016/j.ygyno.2004.06.008]
[Citation(s) in RCA: 11] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2004] [Indexed: 11/30/2022]
Abstract
OBJECTIVE
The lack of an endometrial epithelium-specific promoter has slowed down the development of technically advanced mouse models of endometrial cancer. The aim of this study was to test whether direct in vivo adenoviral-mediated gene delivery can be used to circumvent this problem.
METHODS
Adenoviruses expressing the LacZ reporter gene or the Cre recombinase were injected into the left horn of the mouse uterus. Histochemistry and immunohistochemistry were used to detect expression of the reporter gene as well as targeted deletion of a floxed allele.
RESULTS
Our data demonstrate that in vivo direct injection of adenoviruses can efficiently target the endometrium in the mouse, specifically transducing genes to the glandular epithelial component.
CONCLUSIONS
This approach will allow the generation of more refined and genetically defined mouse models of endometrial cancer. Endometrial gland-specific transient expression of recombinases, such as Cre, may thus be employed to delete engineered alleles of tumor suppressor genes and to activate the expression of latent oncogenes.
Collapse